MP
VCNX

MSD Partners’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

MSD Partners’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,393
Closed -$3.33M – 36
2020
Q2 		$3.33M Sell
4,393
-1,140
-21% -$890K 0.85% 16
2020
Q1 		$4.65M Sell
5,533
-303
-5% -$343K 1.26% 14
2019
Q4 		$5.94M Hold
5,836
– – 1.31% 11
2019
Q3 		$8.79M Buy
+5,836
New +$6.57M 1.18% 12

Other funds holding VCNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MSD Partners's VCNX Position: Q3 2020 in Review

MSD Partners sold out of Vaccinex, Inc. Common Stock (VCNX) in Q3 2020, closing a stake of 4,393 shares — an estimated $3.33M sold.

MSD Partners first reported a position in VCNX in Q3 2019 and held it in 4 quarters. The position peaked at $8.79M in Q3 2019. 16 funds tracked by Wall St. Rank hold VCNX as of Q3 2020.

  • MSD Partners reported no remaining Vaccinex, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • MSD Partners sold 4,393 Vaccinex, Inc. Common Stock shares in Q3 2020, an estimated $3.33M.
  • MSD Partners first reported a position in Vaccinex, Inc. Common Stock in Q3 2019 and held it in 4 quarters.
  • MSD Partners's Vaccinex, Inc. Common Stock position peaked at $8.79M in Q3 2019.
  • 16 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q3 2020.

Based on MSD Partners's 13F filing for Q3 2020, filed 16 Nov 2020.